Chemoradiotherapy Clinical Trials

51 clinical trials for Chemoradiotherapy across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy — RECRUITING · PHASE2
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM) — RECRUITING
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. — RECRUITING · PHASE2
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC — RECRUITING · PHASE3
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India — RECRUITING
Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy — RECRUITING · PHASE2
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC — RECRUITING · PHASE2
Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes — RECRUITING
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer — RECRUITING · PHASE2
Chemoradiotherapy in Unresectable Esophageal Cancer — RECRUITING · PHASE1
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy — RECRUITING · PHASE2
Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients — RECRUITING · PHASE2
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
Toripalimab Combined With Definitive CCRT for LACC Patients — RECRUITING · NA
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma — RECRUITING
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer — RECRUITING · PHASE3
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15) — RECRUITING · NA
Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment — COMPLETED
Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment — NOT_YET_RECRUITING
SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC — NOT_YET_RECRUITING · PHASE2
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer — TERMINATED · PHASE2
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer — COMPLETED · PHASE2
US Radiomics in Advanced Cervical Cancer — COMPLETED
Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring — NOT_YET_RECRUITING · NA
Non-OpeRative MANagement of Rectal Cancer Patients — COMPLETED · PHASE2
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer — COMPLETED · PHASE2
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer — OTHER
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial — OTHER · PHASE2
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) — ACTIVE_NOT_RECRUITING · PHASE2
Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer — OTHER
Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy — OTHER · NA
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab — OTHER
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy — COMPLETED
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients — COMPLETED · PHASE1
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer — OTHER · NA
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. — OTHER · PHASE2
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer — OTHER · PHASE2
Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative — OTHER · NA
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM — NOT_YET_RECRUITING · NA
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy — OTHER
Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma — COMPLETED · PHASE3
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer — OTHER
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma — COMPLETED · PHASE2
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ — OTHER · PHASE1
Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors — OTHER · PHASE3
Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer — OTHER

Refine this search